RxDoctor Payments Data

Janine Zuromski

Adult Health · East Greenwich, RINPI 1245492461

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.5% of the total across 195 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 18.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,360, more than ten times the $18 reported in 2022. Among adult health clinicians in RI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,537in general payments, 2019–2025

Across 195 payments — averaging $23.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$842
  • AstraZeneca$517
  • Pfizer$273
  • Johnson & Johnson$244
  • Bayer$236
  • Novo Nordisk$223
  • plus $2K from 24 others

What the payments were for

  • Food & beverage$4,51499%
  • Education$231%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,537 in reported general payments places this provider in the 90th percentile of 65 adult health providers in Rhode Island.

See all adult health providers in Rhode Island

Medicare billing

Part B allowed, 2024
$54,145
Medicare patients
131
Services billed
772

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab17$133,140
Xeljanz XrTofacitinib Citrate20$120,601
Colchicine11$1,607
Hydroxychloroquine Sulfate50$768
Duloxetine Hcl32$754
MethotrexateMethotrexate Sodium38$739
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen22$326
Prednisone73$250
Atorvastatin Calcium15$204
Allopurinol19$169
Levothyroxine Sodium23$155
Metoprolol Succinate12$152
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen11$149
Gabapentin16$149
Amlodipine Besylate12$118

Paid to pharmacies, not to this prescriber.

Other adult health in East Greenwich

See the full list for Rhode Island

Where these figures come from

Is this you, or does something look wrong? →